カテゴリ： 世界, 医療/バイオ, QYResearch

メシル酸パロキセチンの世界市場2023年：錠剤、カプセル、内服液

■ 英語タイトル：Global Paroxetine Mesylate Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA1677）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA1677
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[メシル酸パロキセチンの世界市場2023年：錠剤、カプセル、内服液]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はメシル酸パロキセチンのグローバル市場について調査・分析し、世界のメシル酸パロキセチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（錠剤、カプセル、内服液）、用途別セグメント分析（大うつ病性障害(MDD)、パニック障害(PD)、強迫性障害(OCD)、全般性不安障害(GAD)、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Solco Healthcare、Sebela Pharmaceuticals、Padagis、Synthon、Noven Pharmaceuticals、Tevaなどが含まれています。メシル酸パロキセチンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、メシル酸パロキセチン市場規模を算出する際に考慮しました。

・メシル酸パロキセチン市場の概要
- 製品の定義
- メシル酸パロキセチンの種類別セグメント
- 世界のメシル酸パロキセチン市場規模：タイプ別分析（錠剤、カプセル、内服液）
- メシル酸パロキセチンの用途別セグメント
- 世界のメシル酸パロキセチン市場規模：用途別分析（大うつ病性障害(MDD)、パニック障害(PD)、強迫性障害(OCD)、全般性不安障害(GAD)、その他）
- 世界のメシル酸パロキセチン市場規模予測（2018年-2029年）
- メシル酸パロキセチンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- メシル酸パロキセチン市場の競争状況およびトレンド

・メシル酸パロキセチンの地域別市場規模
- 北米のメシル酸パロキセチン市場規模（2018年-2029年）
- 米国のメシル酸パロキセチン市場規模（2018年-2029年）
- ヨーロッパのメシル酸パロキセチン市場規模（2018年-2029年）
- アジア太平洋のメシル酸パロキセチン市場規模（2018年-2029年）
- 中国のメシル酸パロキセチン市場規模（2018年-2029年）
- 日本のメシル酸パロキセチン市場規模（2018年-2029年）
- 韓国のメシル酸パロキセチン市場規模（2018年-2029年）
- インドのメシル酸パロキセチン市場規模（2018年-2029年）
- オーストラリアのメシル酸パロキセチン市場規模（2018年-2029年）
- 中南米のメシル酸パロキセチン市場規模（2018年-2029年）
- 中東・アフリカのメシル酸パロキセチン市場規模（2018年-2029年）

・種類別セグメント：錠剤、カプセル、内服液
- 世界のメシル酸パロキセチンのタイプ別販売量（2018年-2023年）
- 世界のメシル酸パロキセチンのタイプ別売上（2018年-2023年）
- 世界のメシル酸パロキセチンのタイプ別価格

・用途別セグメント：大うつ病性障害(MDD)、パニック障害(PD)、強迫性障害(OCD)、全般性不安障害(GAD)、その他
- 世界のメシル酸パロキセチンの用途別販売量（2018年-2023年）
- 世界のメシル酸パロキセチンの用途別売上（2018年-2023年）
- 世界のメシル酸パロキセチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Solco Healthcare、Sebela Pharmaceuticals、Padagis、Synthon、Noven Pharmaceuticals、Teva

・産業チェーンと販売チャネルの分析
- メシル酸パロキセチン産業チェーン分析
- メシル酸パロキセチンの主要原材料
- メシル酸パロキセチンの販売チャネル
- メシル酸パロキセチンのディストリビューター
- メシル酸パロキセチンの主要顧客

・メシル酸パロキセチン市場ダイナミクス
- メシル酸パロキセチンの業界動向
- メシル酸パロキセチン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Paroxetine Mesylate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Paroxetine Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Paroxetine Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Paroxetine Mesylate include Solco Healthcare, Sebela Pharmaceuticals, Padagis, Synthon, Noven Pharmaceuticals and Teva, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Paroxetine Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paroxetine Mesylate.
The Paroxetine Mesylate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Paroxetine Mesylate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paroxetine Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Solco Healthcare
Sebela Pharmaceuticals
Padagis
Synthon
Noven Pharmaceuticals
Teva
Segment by Type
Tablet
Capsule
Oral Solution
Segment by Application
Major Depressive Disorder(MDD)
Panic Disorder(PD)
Obsessive-compulsive Disorder(OCD)
Generalized Anxiety Disorders(GAD)
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paroxetine Mesylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paroxetine Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Paroxetine Mesylate Market Overview
1.1 Product Overview and Scope of Paroxetine Mesylate
1.2 Paroxetine Mesylate Segment by Type
1.2.1 Global Paroxetine Mesylate Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Solution
1.3 Paroxetine Mesylate Segment by Application
1.3.1 Global Paroxetine Mesylate Market Value by Application: (2023-2029)
1.3.2 Major Depressive Disorder(MDD)
1.3.3 Panic Disorder(PD)
1.3.4 Obsessive-compulsive Disorder(OCD)
1.3.5 Generalized Anxiety Disorders(GAD)
1.3.6 Others
1.4 Global Paroxetine Mesylate Market Size Estimates and Forecasts
1.4.1 Global Paroxetine Mesylate Revenue 2018-2029
1.4.2 Global Paroxetine Mesylate Sales 2018-2029
1.4.3 Global Paroxetine Mesylate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Paroxetine Mesylate Market Competition by Manufacturers
2.1 Global Paroxetine Mesylate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Paroxetine Mesylate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Paroxetine Mesylate Average Price by Manufacturers (2018-2023)
2.4 Global Paroxetine Mesylate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Paroxetine Mesylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paroxetine Mesylate, Product Type & Application
2.7 Paroxetine Mesylate Market Competitive Situation and Trends
2.7.1 Paroxetine Mesylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paroxetine Mesylate Players Market Share by Revenue
2.7.3 Global Paroxetine Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paroxetine Mesylate Retrospective Market Scenario by Region
3.1 Global Paroxetine Mesylate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Paroxetine Mesylate Global Paroxetine Mesylate Sales by Region: 2018-2029
3.2.1 Global Paroxetine Mesylate Sales by Region: 2018-2023
3.2.2 Global Paroxetine Mesylate Sales by Region: 2024-2029
3.3 Global Paroxetine Mesylate Global Paroxetine Mesylate Revenue by Region: 2018-2029
3.3.1 Global Paroxetine Mesylate Revenue by Region: 2018-2023
3.3.2 Global Paroxetine Mesylate Revenue by Region: 2024-2029
3.4 North America Paroxetine Mesylate Market Facts & Figures by Country
3.4.1 North America Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Paroxetine Mesylate Sales by Country (2018-2029)
3.4.3 North America Paroxetine Mesylate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paroxetine Mesylate Market Facts & Figures by Country
3.5.1 Europe Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Paroxetine Mesylate Sales by Country (2018-2029)
3.5.3 Europe Paroxetine Mesylate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paroxetine Mesylate Market Facts & Figures by Country
3.6.1 Asia Pacific Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Paroxetine Mesylate Sales by Country (2018-2029)
3.6.3 Asia Pacific Paroxetine Mesylate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Paroxetine Mesylate Market Facts & Figures by Country
3.7.1 Latin America Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Paroxetine Mesylate Sales by Country (2018-2029)
3.7.3 Latin America Paroxetine Mesylate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paroxetine Mesylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Paroxetine Mesylate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Paroxetine Mesylate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Paroxetine Mesylate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Paroxetine Mesylate Sales by Type (2018-2029)
4.1.1 Global Paroxetine Mesylate Sales by Type (2018-2023)
4.1.2 Global Paroxetine Mesylate Sales by Type (2024-2029)
4.1.3 Global Paroxetine Mesylate Sales Market Share by Type (2018-2029)
4.2 Global Paroxetine Mesylate Revenue by Type (2018-2029)
4.2.1 Global Paroxetine Mesylate Revenue by Type (2018-2023)
4.2.2 Global Paroxetine Mesylate Revenue by Type (2024-2029)
4.2.3 Global Paroxetine Mesylate Revenue Market Share by Type (2018-2029)
4.3 Global Paroxetine Mesylate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Paroxetine Mesylate Sales by Application (2018-2029)
5.1.1 Global Paroxetine Mesylate Sales by Application (2018-2023)
5.1.2 Global Paroxetine Mesylate Sales by Application (2024-2029)
5.1.3 Global Paroxetine Mesylate Sales Market Share by Application (2018-2029)
5.2 Global Paroxetine Mesylate Revenue by Application (2018-2029)
5.2.1 Global Paroxetine Mesylate Revenue by Application (2018-2023)
5.2.2 Global Paroxetine Mesylate Revenue by Application (2024-2029)
5.2.3 Global Paroxetine Mesylate Revenue Market Share by Application (2018-2029)
5.3 Global Paroxetine Mesylate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Solco Healthcare
6.1.1 Solco Healthcare Corporation Information
6.1.2 Solco Healthcare Description and Business Overview
6.1.3 Solco Healthcare Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Solco Healthcare Paroxetine Mesylate Product Portfolio
6.1.5 Solco Healthcare Recent Developments/Updates
6.2 Sebela Pharmaceuticals
6.2.1 Sebela Pharmaceuticals Corporation Information
6.2.2 Sebela Pharmaceuticals Description and Business Overview
6.2.3 Sebela Pharmaceuticals Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sebela Pharmaceuticals Paroxetine Mesylate Product Portfolio
6.2.5 Sebela Pharmaceuticals Recent Developments/Updates
6.3 Padagis
6.3.1 Padagis Corporation Information
6.3.2 Padagis Description and Business Overview
6.3.3 Padagis Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Padagis Paroxetine Mesylate Product Portfolio
6.3.5 Padagis Recent Developments/Updates
6.4 Synthon
6.4.1 Synthon Corporation Information
6.4.2 Synthon Description and Business Overview
6.4.3 Synthon Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Synthon Paroxetine Mesylate Product Portfolio
6.4.5 Synthon Recent Developments/Updates
6.5 Noven Pharmaceuticals
6.5.1 Noven Pharmaceuticals Corporation Information
6.5.2 Noven Pharmaceuticals Description and Business Overview
6.5.3 Noven Pharmaceuticals Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Noven Pharmaceuticals Paroxetine Mesylate Product Portfolio
6.5.5 Noven Pharmaceuticals Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Paroxetine Mesylate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Paroxetine Mesylate Product Portfolio
6.6.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paroxetine Mesylate Industry Chain Analysis
7.2 Paroxetine Mesylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paroxetine Mesylate Production Mode & Process
7.4 Paroxetine Mesylate Sales and Marketing
7.4.1 Paroxetine Mesylate Sales Channels
7.4.2 Paroxetine Mesylate Distributors
7.5 Paroxetine Mesylate Customers
8 Paroxetine Mesylate Market Dynamics
8.1 Paroxetine Mesylate Industry Trends
8.2 Paroxetine Mesylate Market Drivers
8.3 Paroxetine Mesylate Market Challenges
8.4 Paroxetine Mesylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Paroxetine Mesylate Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Paroxetine Mesylate Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Paroxetine Mesylate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Paroxetine Mesylate Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global Paroxetine Mesylate Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Paroxetine Mesylate Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Paroxetine Mesylate Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Paroxetine Mesylate Average Price (US$/g) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Paroxetine Mesylate, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Paroxetine Mesylate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Paroxetine Mesylate, Product Type & Application
Table 12. Global Key Manufacturers of Paroxetine Mesylate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Paroxetine Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxetine Mesylate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Paroxetine Mesylate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Paroxetine Mesylate Sales by Region (2018-2023) & (Kg)
Table 18. Global Paroxetine Mesylate Sales Market Share by Region (2018-2023)
Table 19. Global Paroxetine Mesylate Sales by Region (2024-2029) & (Kg)
Table 20. Global Paroxetine Mesylate Sales Market Share by Region (2024-2029)
Table 21. Global Paroxetine Mesylate Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Paroxetine Mesylate Revenue Market Share by Region (2018-2023)
Table 23. Global Paroxetine Mesylate Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Paroxetine Mesylate Revenue Market Share by Region (2024-2029)
Table 25. North America Paroxetine Mesylate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Paroxetine Mesylate Sales by Country (2018-2023) & (Kg)
Table 27. North America Paroxetine Mesylate Sales by Country (2024-2029) & (Kg)
Table 28. North America Paroxetine Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Paroxetine Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Paroxetine Mesylate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Paroxetine Mesylate Sales by Country (2018-2023) & (Kg)
Table 32. Europe Paroxetine Mesylate Sales by Country (2024-2029) & (Kg)
Table 33. Europe Paroxetine Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Paroxetine Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Paroxetine Mesylate Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Paroxetine Mesylate Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific Paroxetine Mesylate Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific Paroxetine Mesylate Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Paroxetine Mesylate Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Paroxetine Mesylate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Paroxetine Mesylate Sales by Country (2018-2023) & (Kg)
Table 42. Latin America Paroxetine Mesylate Sales by Country (2024-2029) & (Kg)
Table 43. Latin America Paroxetine Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Paroxetine Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Paroxetine Mesylate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Paroxetine Mesylate Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa Paroxetine Mesylate Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa Paroxetine Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Paroxetine Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Paroxetine Mesylate Sales (Kg) by Type (2018-2023)
Table 51. Global Paroxetine Mesylate Sales (Kg) by Type (2024-2029)
Table 52. Global Paroxetine Mesylate Sales Market Share by Type (2018-2023)
Table 53. Global Paroxetine Mesylate Sales Market Share by Type (2024-2029)
Table 54. Global Paroxetine Mesylate Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Paroxetine Mesylate Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Paroxetine Mesylate Revenue Market Share by Type (2018-2023)
Table 57. Global Paroxetine Mesylate Revenue Market Share by Type (2024-2029)
Table 58. Global Paroxetine Mesylate Price (US$/g) by Type (2018-2023)
Table 59. Global Paroxetine Mesylate Price (US$/g) by Type (2024-2029)
Table 60. Global Paroxetine Mesylate Sales (Kg) by Application (2018-2023)
Table 61. Global Paroxetine Mesylate Sales (Kg) by Application (2024-2029)
Table 62. Global Paroxetine Mesylate Sales Market Share by Application (2018-2023)
Table 63. Global Paroxetine Mesylate Sales Market Share by Application (2024-2029)
Table 64. Global Paroxetine Mesylate Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Paroxetine Mesylate Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Paroxetine Mesylate Revenue Market Share by Application (2018-2023)
Table 67. Global Paroxetine Mesylate Revenue Market Share by Application (2024-2029)
Table 68. Global Paroxetine Mesylate Price (US$/g) by Application (2018-2023)
Table 69. Global Paroxetine Mesylate Price (US$/g) by Application (2024-2029)
Table 70. Solco Healthcare Corporation Information
Table 71. Solco Healthcare Description and Business Overview
Table 72. Solco Healthcare Paroxetine Mesylate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 73. Solco Healthcare Paroxetine Mesylate Product
Table 74. Solco Healthcare Recent Developments/Updates
Table 75. Sebela Pharmaceuticals Corporation Information
Table 76. Sebela Pharmaceuticals Description and Business Overview
Table 77. Sebela Pharmaceuticals Paroxetine Mesylate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 78. Sebela Pharmaceuticals Paroxetine Mesylate Product
Table 79. Sebela Pharmaceuticals Recent Developments/Updates
Table 80. Padagis Corporation Information
Table 81. Padagis Description and Business Overview
Table 82. Padagis Paroxetine Mesylate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 83. Padagis Paroxetine Mesylate Product
Table 84. Padagis Recent Developments/Updates
Table 85. Synthon Corporation Information
Table 86. Synthon Description and Business Overview
Table 87. Synthon Paroxetine Mesylate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 88. Synthon Paroxetine Mesylate Product
Table 89. Synthon Recent Developments/Updates
Table 90. Noven Pharmaceuticals Corporation Information
Table 91. Noven Pharmaceuticals Description and Business Overview
Table 92. Noven Pharmaceuticals Paroxetine Mesylate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 93. Noven Pharmaceuticals Paroxetine Mesylate Product
Table 94. Noven Pharmaceuticals Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Paroxetine Mesylate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 98. Teva Paroxetine Mesylate Product
Table 99. Teva Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Paroxetine Mesylate Distributors List
Table 103. Paroxetine Mesylate Customers List
Table 104. Paroxetine Mesylate Market Trends
Table 105. Paroxetine Mesylate Market Drivers
Table 106. Paroxetine Mesylate Market Challenges
Table 107. Paroxetine Mesylate Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Paroxetine Mesylate
Figure 2. Global Paroxetine Mesylate Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Paroxetine Mesylate Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Paroxetine Mesylate Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Paroxetine Mesylate Market Share by Application in 2022 & 2029
Figure 9. Major Depressive Disorder(MDD)
Figure 10. Panic Disorder(PD)
Figure 11. Obsessive-compulsive Disorder(OCD)
Figure 12. Generalized Anxiety Disorders(GAD)
Figure 13. Others
Figure 14. Global Paroxetine Mesylate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Paroxetine Mesylate Market Size (2018-2029) & (US$ Million)
Figure 16. Global Paroxetine Mesylate Sales (2018-2029) & (Kg)
Figure 17. Global Paroxetine Mesylate Average Price (US$/g) & (2018-2029)
Figure 18. Paroxetine Mesylate Report Years Considered
Figure 19. Paroxetine Mesylate Sales Share by Manufacturers in 2022
Figure 20. Global Paroxetine Mesylate Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Paroxetine Mesylate Players: Market Share by Revenue in 2022
Figure 22. Paroxetine Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Paroxetine Mesylate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Paroxetine Mesylate Sales Market Share by Country (2018-2029)
Figure 25. North America Paroxetine Mesylate Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Paroxetine Mesylate Sales Market Share by Country (2018-2029)
Figure 29. Europe Paroxetine Mesylate Revenue Market Share by Country (2018-2029)
Figure 30. Germany Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Paroxetine Mesylate Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Paroxetine Mesylate Revenue Market Share by Region (2018-2029)
Figure 37. China Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Taiwan Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Philippines Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Paroxetine Mesylate Sales Market Share by Country (2018-2029)
Figure 48. Latin America Paroxetine Mesylate Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Paroxetine Mesylate Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa Paroxetine Mesylate Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. U.A.E Paroxetine Mesylate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of Paroxetine Mesylate by Type (2018-2029)
Figure 58. Global Revenue Market Share of Paroxetine Mesylate by Type (2018-2029)
Figure 59. Global Paroxetine Mesylate Price (US$/g) by Type (2018-2029)
Figure 60. Global Sales Market Share of Paroxetine Mesylate by Application (2018-2029)
Figure 61. Global Revenue Market Share of Paroxetine Mesylate by Application (2018-2029)
Figure 62. Global Paroxetine Mesylate Price (US$/g) by Application (2018-2029)
Figure 63. Paroxetine Mesylate Value Chain
Figure 64. Paroxetine Mesylate Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • リファマイシンのグローバル市場展望 2023年-2029年：タブレット、カプセル
  • 臓器拒絶反応予防薬のグローバル市場展望 2023年-2029年：内服液、注射剤、カプセル
  • ドフェチリドのグローバル市場展望 2023年-2029年：カプセル、その他
  • 下垂体サプリメントの世界市場2023年：カプセル、錠剤
  • 熊胆粉の世界市場2023年：ピース、用量、粒子、カプセル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA1677 )"メシル酸パロキセチンの世界市場2023年：錠剤、カプセル、内服液" (英文：Global Paroxetine Mesylate Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。